The Role of Pharmacy in the Management of Patients with Temporomandibular Disorders and Orofacial Pain
Authors:
- Gayle A. BrazeauGBGayle A. Brazeau
- Joseph L. RileyJRJoseph L. Riley
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Journal of the American Pharmaceutical Association
- Vol. 38 (3) , 354-363
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Temporomandibular disorders, headaches, and neck pain after motor vehicle accidents: A pilot investigation of persistence and litigation effectsThe Journal of Prosthetic Dentistry, 1997
- Physical therapy: A critiqueOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1997
- Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of ratsBrain Research, 1996
- The effects of the GABA agonist, baclofen, on sleep and breathingEuropean Respiratory Journal, 1995
- A New Approach to Control Central Deafferentation Pain: Spinal Intrathecal BaclofenStereotactic and Functional Neurosurgery, 1995
- Brief group cognitive-behavioral intervention for temporomandibular disordersPain, 1994
- Do benzodiazepines have a role in chronic pain management?Pain, 1994
- Comparison of Amitriptyline, Cyclobenzaprine, and Placebo in the Treatment of FibromyalgiaArthritis & Rheumatism, 1994
- Efficacy of multidisciplinary pain treatment centers: a meta-analytic reviewPain, 1992
- Pain Mechanisms: A New TheoryScience, 1965